WHWK — Whitehawk Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Whitehawk Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	42.6	149	173	109	47.2
Net Total Accounts Receivable
Net Total Receivables	—	—	1.86	5.49	5.9
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	44.7	151	180	125	61.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.186	0.614	2.03	5.97	7.63
Net Intangible Assets
Other Long Term Assets
Total Assets	44.9	158	184	132	70.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.87	15.3	18.8	26.4	17.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.87	21.5	25.9	27.2	17.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	43.1	136	158	105	52.5
Total Liabilities & Shareholders' Equity	44.9	158	184	132	70.3
Total Common Shares Outstanding